SCHEMBL8933233

SCHEMBL8933233

CCCCCCCC1CCC(c2ccc(-c3ccc(-c4ccc(CC)c(F)c4F)cc3)c(F)c2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.38
CYP2C9 P11712 3/20 0.38
RARB P10826 1/20 0.37
FASN P49327 1/20 0.36
APP P05067 2/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
RORC P51449 3/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
RORA P35398 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
CYP2C8 P10632 1/20 0.33
S1PR3 Q99500 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
FFAR4 Q5NUL3 1/20 0.32
SPHK1 Q9NYA1 1/20 0.32
P2RY14 Q15391 1/20 0.32
DGAT1 O75907 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8932885 0.99 CYP3A4 (0.38) CYP3A4CYP2C9RARBFASNAPP
SCHEMBL8958989 0.97 CYP3A4 (0.36) CYP3A4CYP2C9RARBFASNAPP
SCHEMBL8958717 0.96 CYP3A4 (0.36) CYP3A4CYP2C9RARBFASNAPP
SCHEMBL18779809 0.94 CYP2C9 (0.40) CYP3A4CYP2C9RARBFASNAPP
SCHEMBL8933424 0.93 RARB (0.36) CYP3A4CYP2C9RARBFASNAPP
SCHEMBL8933020 0.93 RARB (0.39) CYP3A4CYP2C9RARBFASNAPP
SCHEMBL8932971 0.93 RARB (0.39) CYP3A4CYP2C9RARBFASNAPP
SCHEMBL8933268 0.93 RARB (0.36) CYP3A4CYP2C9RARBFASNAPP
SCHEMBL8933277 0.93 RARB (0.39) CYP3A4CYP2C9RARBFASNAPP
SCHEMBL8933172 0.93 RARB (0.39) CYP3A4CYP2C9RARBFASNAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8187494-B2 Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-05-29 US disclosed
US-20100309402-A1 FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100309402-A1 FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE KIF23, HCN3, FZD7 CYP3A4 1445/4885CYP2C9 2391/4885RARB 3042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.